Valerianna K. Amorosa, MD

Infectious Diseases
Accepting new patients
Sees patients age 18 and up
MacGregor Infection Medicine and Travel Program
Make an appointmentCall 800-789-7366
Penn Medicine Provider

About me

  • Medical Director for Penn Home Infusion Therapy (PHIT)
  • Professor of Clinical Medicine (Infectious Diseases)

My education and training

  • Medical School: Washington University in St. Louis
  • Residency: University of Pennsylvania Health System
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Amorosa is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Hamiter M, Amorosa V, Belden K, Gidley PW, Mohan S, Perry B, Kim AH. Skull Base Osteomyelitis: Historical Perspective, Diagnosis and Management Update. , Otolaryngol Clin North Am. , 56(5): 2023,987-1001

Daniel J Escobar, Maria Lanzi. Pouné Saberi, Ruby Love, Darren R Linkin, John J Kelly, Darshana Jhala, Valerianna Amorosa, Mary Hofmann, Jeffrey B Doyon Mitigation of a COVID-19 Outbreak in a Nursing Home Through Serial Testing of Residents and Staff , Clin Infect Dis , 72(9): 2021,394–396

Amorosa VK and Garst R Monoclonal Antibodies for COVID-19 and Emerging Variants , Infusion, 27(3): 2021,36-43

Xue Z, Coughlin R, Amorosa V, Quinn R, Schiavone P, Stoner N, Kinosian B, Compher C. Factors Associated With Central Line-Associated Bloodstream Infections in a Cohort of Adult Home Parenteral Nutrition Patients. , J Parenter Enteral Nutr. , 44(8): 2020

Chida N, Brown C, Mathad J, Carpenter K, Nelson G, Schechter MC, Rebolledo PA, Fabre V, Cantillo DS, Longworth S, Amorosa V, Petrauskis C, Boulanger C, Cain N, Gupta A, McKenzie-White J, Bollinger R, Melia M. Developing an Assessment Framework for Essential Internal Medicine Subspecialty Topics. , J Grad Med Educ. , 10(3): 2018,331-335

Chida N, Brown C, Mathad J, Carpenter K, Nelson G, Schechter MC, Giles N, Rebolledo PA, Ray S, Fabre V, Cantillo DS, Longworth S, Amorosa V, Petrauskis C, Boulanger C, Cain N, Gupta A, McKenzie-White J, Bollinger R, Melia MT. Internal Medicine Residents' Knowledge and Practice of Pulmonary Tuberculosis Diagnosis. , Open Forum Infect Dis. , 5(7): 2018

Gowda Charitha, Sheikh Umar, Maier Andrew W, Chang Kyong-Mi, Kaplan David E, Re Vincent Lo, Amorosa Valerianna K Strategies to Improve Hepatocellular Carcinoma Surveillance in Veterans With Hepatitis B Infection , Fed Pract, 34(Suppl 4): 2017,S30-S39

Petersen T, Lee YJ, Osinusi A, Amorosa VK, Wang C, Kang M, Matining R, Zhang X, Dou D, Umbleja T, Kottilil S, Peters MG Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin , AIDS Res Hum Retroviruses , 32(7): 2016,660-7

Hill A, Roberts T, Amorosa V, Pourmand K, Matthews G, Cooke G, Khan H, Cohn J Can HCV antigen testing replace HCV RNA analysis, for monitoring of DAA-based treatment for Hepatitis C? , AASLD: 2015

Gowda C, Sheikh U, Maier A, Chang KM, Kaplan DE, Lo Re III V, Amorosa V Identifying barriers and potential strategies to improve HCC surveillance for HBV-infected veterans , IDSA: 2015